Primary or Secondary Prophylactic Treatment
1 clinical trials · Condition
◉ Watch Primary or Secondary Prophylactic Treatment
| Record | Firm | Date |
|---|---|---|
| Nivestimâ„¢ in Treatment of Malignant Diseases (NCT01627990) | Hospira, now a wholly owned subsidiary of Pfizer | 2011-06-01 |
Track Primary or Secondary Prophylactic Treatment automatically
Every clearance here is in the API, with alerts when new ones post.